| 来源类型 | Commentary |
| 规范类型 | 评论 |
| The high cost of Hepatitis C drugs | |
| Hagop M. Kantarjian | |
| 发表日期 | 2017-11-27 |
| 出版年 | 2017 |
| 语种 | 英语 |
| 概述 | Nonresident fellow Hagop Kantarjian examines how the high price of Hepatitis C drugs has made treatment unaffordable, leading to the ... |
| 摘要 | Nonresident fellow Hagop Kantarjian examines how the high price of Hepatitis C drugs has made treatment unaffordable, leading to the deaths of up to 500,000 people annually that could prevented. Houston Chronicle: http://bit.ly/2iYq3YX. |
| 主题 | Center for Health and Biosciences |
| URL | https://www.bakerinstitute.org/research/cost-high-hepatitis-c-drug/ |
| 来源智库 | James A. Baker III Institute for Public Policy (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/80157 |
| 推荐引用方式 GB/T 7714 | Hagop M. Kantarjian . The high cost of Hepatitis C drugs. 2017. |
| 条目包含的文件 | 条目无相关文件。 | |||||
| 个性服务 |
| 推荐该条目 |
| 保存到收藏夹 |
| 导出为Endnote文件 |
| 谷歌学术 |
| 谷歌学术中相似的文章 |
| [Hagop M. Kantarjian ]的文章 |
| 百度学术 |
| 百度学术中相似的文章 |
| [Hagop M. Kantarjian ]的文章 |
| 必应学术 |
| 必应学术中相似的文章 |
| [Hagop M. Kantarjian ]的文章 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
